1. Home
  2. CACI vs RGEN Comparison

CACI vs RGEN Comparison

Compare CACI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • RGEN
  • Stock Information
  • Founded
  • CACI 1962
  • RGEN 1981
  • Country
  • CACI United States
  • RGEN United States
  • Employees
  • CACI N/A
  • RGEN N/A
  • Industry
  • CACI EDP Services
  • RGEN Medical/Dental Instruments
  • Sector
  • CACI Technology
  • RGEN Health Care
  • Exchange
  • CACI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • CACI 7.3B
  • RGEN 8.0B
  • IPO Year
  • CACI 1979
  • RGEN N/A
  • Fundamental
  • Price
  • CACI $461.42
  • RGEN $118.15
  • Analyst Decision
  • CACI Buy
  • RGEN Buy
  • Analyst Count
  • CACI 13
  • RGEN 12
  • Target Price
  • CACI $502.83
  • RGEN $172.67
  • AVG Volume (30 Days)
  • CACI 298.2K
  • RGEN 819.3K
  • Earning Date
  • CACI 04-23-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • CACI N/A
  • RGEN N/A
  • EPS Growth
  • CACI 22.32
  • RGEN N/A
  • EPS
  • CACI 21.19
  • RGEN N/A
  • Revenue
  • CACI $8,361,975,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • CACI $14.65
  • RGEN $13.93
  • Revenue Next Year
  • CACI $7.25
  • RGEN $14.35
  • P/E Ratio
  • CACI $21.78
  • RGEN N/A
  • Revenue Growth
  • CACI 14.16
  • RGEN 4.88
  • 52 Week Low
  • CACI $318.60
  • RGEN $102.97
  • 52 Week High
  • CACI $588.26
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • CACI 54.21
  • RGEN 38.20
  • Support Level
  • CACI $460.14
  • RGEN $120.11
  • Resistance Level
  • CACI $477.78
  • RGEN $129.42
  • Average True Range (ATR)
  • CACI 10.71
  • RGEN 6.02
  • MACD
  • CACI -3.40
  • RGEN -1.20
  • Stochastic Oscillator
  • CACI 41.83
  • RGEN 5.96

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: